Camp4

IPO

CAMP4 Therapeutics - Pioneering a new class of RNA medicines to increase targeted gene expression

Cambridge, United States · Founded 2016 · $180.0M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$180.0M
Last Round
$50.0M Private EquitySep 2025
Rounds
3

About

CAMP4 Therapeutics is a clinical-stage biotech pioneering programmable RNA therapeutics for haploinsufficient diseases. Its regRNA platform combines gene regulation insights with computational biology to increase gene dosage in conditions where one functional gene copy is insufficient, targeting rare neurological and other genetic disorders.

Summary

Camp4 is a Healthcare company based in Cambridge, United States, founded in 2016. It has raised $180.0M in total across 3 rounds, most recently a $50.0M Private Equity round in Sep 2025. Investors include Coastlands Capital, Patient Square Capital and Polaris Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquitySep 2025
$50.0M

Sign up to see all 4 rounds

Series A through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Camp4 on Indexed.vc
<a href="https://indexed.vc/companies/camp4"><img src="https://indexed.vc/api/badge/company/camp4" alt="Camp4 on Indexed.vc" width="260" height="76" /></a>